Abstract:A Cu+/Ca2+ dual‐overload strategy assisted with metabolic disruption is proposed for anti‐tumor therapy. Precise CuS/CaCO3 delivery triggers irreversible Cu+/Ca2+ dual‐overload of tumor cells. Moreover, intracellular acidosis and MCT4 inhibition aggravated by α‐CHCA and penthiopyrad in CCPCR NPs promote the Fenton‐like reaction and metabolic disruption, thus inducing immune activation and tumor cell apoptosis. Ion interference including copper (Cu+)/calcium (Ca2+) overload activate cell‐specific death channels, damage mitochondria and disrupt cellular homeostasis, showing great potential in anti‐tumor therapy. However, the complex metabolic environment and the powerful self‐protection of tumors cause clinical failure of ion interference. Thus, metabolic disruption is expected an innovative strategy for the enhancement of ion interference. Herein, CuS‐α‐CHCA&penthiopyrad@CaCO3‐RGD nanoparticles (CCPCR NPs) are prepared to provide a Cu+/Ca2+ dual‐overload anti‐tumor therapy assisted by metabolic‐symbiosis‐destruction strategy, realizing the collapse of tumor self‐protection. Specifically, precise CuS and CaCO3 delivery triggered irreversible Cu+/Ca2+ dual‐overload and reactive oxygen species (ROS) attack toward 4T1 cells. Meanwhile, α‐CHCA and penthiopyrad disturbed the metabolic symbiotic environment by disrupting the TCA cycle and preventing lactate efflux to aggravate intracellular acidosis and promote Fenton‐like reaction of Cu+, enhancing the sensitivity of tumor cells to copper death and Ca2+ overload. Further, aided by the metabolism of symbiosis, the destroyed tumor cells further activate the polarization of M1 macrophages and the maturation and antigen cross‐presentation of dendritic cells (DCs), which further eliminate tumor cells. In summary, an amplified anti‐tumor dual‐ion interference strategy assisted by metabolic symbiotic destruction is established, which is of great significance in improving the clinical effect of ion therapy for tumors.

Biodegradable Ferrous Sulfide-Based Nanocomposites for Tumor Theranostics through Specific Intratumoral Acidosis-Induced Metabolic Symbiosis Disruption

A Two-Pronged Nanostrategy of Iron Metabolism Disruption to Synergize Tumor Therapy by Triggering the Paraptosis-Apoptosis Hybrid Pathway

Degradable FeCuS-Lipid Nanoparticles Confer Ultrasound-Activated CO Release and O2-Independent Radical Production for Synergistic Therapy

Amorphous Fe‐Based Nanoagents for Self‐Enhanced Chemodynamic Therapy by Re‐Establishing Tumor Acidosis

FeS2@COF Based Nanocarrier for Photothermal-Enhanced Chemodynamic/thermodynamic Tumor Therapy and Immunotherapy Via Reprograming Tumor-Associated Macrophages

Intracellular Mutual Promotion of Redox Homeostasis Regulation and Iron Metabolism Disruption for Enduring Chemodynamic Therapy

Intracellular self-aggregation of biomimetic Fe3O4 nanoparticles for enhanced ferroptosis-inducing therapy of breast cancer

Integration of Fe3O4 with Bi2S3 for Multi-Modality Tumor Theranostics.

The Sustainability of Energy Conversion Inhibition for Tumor Ferroptosis Therapy and Chemotherapy

Biomineralized nanomedicine for enhanced cancer therapy through in situ toxification and amplified Ca 2+ overload

Clearable Theranostic Platform with pH-independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.

A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling

Cu+/Ca2+ Dual‐Overload Strategy Assisted by Metabolic‐Symbiotic‐Destruction for Tumor Apoptosis and Tumor Immune Activation

Protease‐Activatable Nanozyme with Photoacoustic and Tumor‐Enhanced Magnetic Resonance Imaging for Photothermal Ferroptosis Cancer Therapy

H2 S-Scavenged and Activated Iron Oxide-Hydroxide Nanospindles for MRI-Guided Photothermal Therapy and Ferroptosis in Colon Cancer.

Disrupting Intracellular Iron Homeostasis by Engineered Metal‐Organic Framework for Nanocatalytic Tumor Therapy in Synergy with Autophagy Amplification‐Promoted Ferroptosis

Enhanced ferroptosis therapy with a "nano-destructor" by disrupting intracellular redox and iron homeostasis

Antiferromagnetic Pyrite as the Tumor Microenvironment-Mediated Nanoplatform for Self-Enhanced Tumor Imaging and Therapy.

MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy

Biodegradable calcium sulfide-based nanomodulators for H 2 S-boosted Ca 2+ -involved synergistic cascade cancer therapy

Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.